You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Meclofenamate sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for meclofenamate sodium and what is the scope of freedom to operate?

Meclofenamate sodium is the generic ingredient in three branded drugs marketed by Quantum Pharmics, Am Therap, Ani Pharms, Barr, Chartwell Rx, Mylan, Par Pharm, Usl Pharma, Vitarine, Watson Labs, and Parke Davis, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for meclofenamate sodium. One supplier is listed for this compound.

Summary for meclofenamate sodium
Recent Clinical Trials for meclofenamate sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all meclofenamate sodium clinical trials

US Patents and Regulatory Information for meclofenamate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071081-002 Sep 3, 1986 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Parke Davis MECLOMEN meclofenamate sodium CAPSULE;ORAL 018006-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071641-001 Aug 11, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Parke Davis MECLOMEN meclofenamate sodium CAPSULE;ORAL 018006-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ani Pharms MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071469-002 Apr 15, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.